Risk of early progression according to circulating ESR1 mutation, CA-15.3 and cfDNA increases under first-line anti-aromatase treatment in metastatic breast cancer

Overview of attention for article published in Breast Cancer Research, May 2020

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 27 Dimensions

Readers on

mendeley: 31 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 44 followers.

Pubmed: Risk of early progression according to circulating ESR1 mutation, CA-15.3 and cfDNA increases under first-line anti-aromatase treatment in metastatic breast cancer. https://t.co/pzbAyjkt4b

09 Nov 2020

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.